Clinical trial NCT07167446
Status: RecruitingEarly phase 1Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
- Record number
- NCT07167446
- Status
- Recruiting
- Type and phase
- Clinical trial, early phase 1
- Participants
- Target: 30
- Condition (as registered)
- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC), Peripheral Neuropathy Due to Chemotherapy
- Countries
- United States
- Topic in the guide
- Cancer Treatment, Neuropathic Pain
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: October 14, 2025
- End of data collection for primary results: September 5, 2027 (expected)
- Trial completion: September 7, 2028 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Cancer Treatment: ongoing trials · Neuropathic Pain: ongoing trials · Thinking of taking part? Which specialist to see